| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10910883 | Lung Cancer | 2015 | 9 Pages |
Abstract
Our findings indicate that chemical hypoxia may augment cancer cell stemness and drug resistance in CD166-positive stem cells. Therefore, targeting the stem-like cell population, especially CD166-positive cells, may represent a novel therapeutic strategy to treat lung cancer.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Mingchuan Zhao, Yishi Zhang, Huijun Zhang, Shaohua Wang, Mengmeng Zhang, Xi Chen, Heyong Wang, Gang Zeng, Xiaofeng Chen, Gentao Liu, Caicun Zhou,